Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk
Links shared publicly online about this topic.
- 468total visits
Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk
View full resource at instapaper.com
Tags: Heart, Post Heart Attack Medication, High Blood Pressure Medication, Kidney Health, Urinary System, Micardis
Most Recently Shared on March 2, 2011 at 4:37 pm By:
No support for dual RAS-blocking therapy over monotherapy in high–risk patients with low eGFR or albuminuria: http://bit.ly/gRG0xt
Family Medicine Article | Albuminuria
mdlinx.com — “Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk” View full resource at mdlinx.com
Most Recently Shared on March 2, 2011 at 12:46 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk:... http://bit.ly/eU1jHF #FamPractice
Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies -- Tobe et al., 10.1161/CIRCULATIONAHA.110.964171 -- Circulation
circ.ahajournals.org — “Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk: Results From the ONTARGET and TRANSCEND Studies -- Tobe et al., 10.1161/CIRCULATIONAHA.110.964171 -- Circulation” View full resource at circ.ahajournals.org
Most Recently Shared on March 1, 2011 at 4:00 pm By:
James Underberg Internist, Physician, and Doctor
http://bit.ly/frxYdt CV& Renal Outcomes With Telmisartan & or Ramipril in High Renal Risk:From ONTARGET& TRANSCEND-no benefit of dual Rx
Advertisement
